Zenjiro Sampei

1.3k total citations
14 papers, 552 citations indexed

About

Zenjiro Sampei is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Zenjiro Sampei has authored 14 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Zenjiro Sampei's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Protein purification and stability (5 papers) and Complement system in diseases (4 papers). Zenjiro Sampei is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Protein purification and stability (5 papers) and Complement system in diseases (4 papers). Zenjiro Sampei collaborates with scholars based in Japan, United States and Singapore. Zenjiro Sampei's co-authors include Tomoyuki Igawa, Kunihiro Hattori, Taichi Kuramochi, Takehisa Kitazawa, Kenta Haraya, Shinya Ishii, Hiroyuki Tsunoda, Tetsuhiro Soeda, Kazutaka Yoshihashi and Atsushi Muto and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Zenjiro Sampei

14 papers receiving 507 citations

Peers

Zenjiro Sampei
Saskia Meyer Netherlands
Robert Oldham United Kingdom
Justin B. Goh Australia
Laura Cons Switzerland
Shaughn H. Bryant United States
Olga Ignatovich United Kingdom
Ivica Fucek Germany
Diane Stone United States
GT Stevenson United Kingdom
D. A. Vallera United States
Saskia Meyer Netherlands
Zenjiro Sampei
Citations per year, relative to Zenjiro Sampei Zenjiro Sampei (= 1×) peers Saskia Meyer

Countries citing papers authored by Zenjiro Sampei

Since Specialization
Citations

This map shows the geographic impact of Zenjiro Sampei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zenjiro Sampei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zenjiro Sampei more than expected).

Fields of papers citing papers by Zenjiro Sampei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zenjiro Sampei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zenjiro Sampei. The network helps show where Zenjiro Sampei may publish in the future.

Co-authorship network of co-authors of Zenjiro Sampei

This figure shows the co-authorship network connecting the top 25 collaborators of Zenjiro Sampei. A scholar is included among the top collaborators of Zenjiro Sampei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zenjiro Sampei. Zenjiro Sampei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sampei, Zenjiro, Kenta Haraya, Siok Wan Gan, et al.. (2024). Beyond Recycling Antibodies: Crovalimab’s Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment. International Journal of Molecular Sciences. 25(21). 11679–11679. 3 indexed citations
2.
Yano, Mariko, Shunsuke Ito, Tomochika Matsushita, et al.. (2023). Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4 + T cell interleukin-2 secretion. mAbs. 15(1). 2253570–2253570. 3 indexed citations
3.
Sampei, Zenjiro, Christine X. Koo, Ying Xiu Toh, et al.. (2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 12(2). 36–36. 3 indexed citations
4.
Koga, Hikaru, Takashi Yamano, Juan Felipe Betancur, et al.. (2023). Efficient production of bispecific antibody by FAST-Ig TM and its application to NXT007 for the treatment of hemophilia A. mAbs. 15(1). 2222441–2222441. 13 indexed citations
5.
Koga, Hikaru, Hirotake Shiraiwa, Zenjiro Sampei, et al.. (2023). Monte Carlo Thompson sampling-guided design for antibody engineering. mAbs. 15(1). 2244214–2244214. 1 indexed citations
6.
Hori, Yuji, Hitoshi Katada, Yuki Noguchi, et al.. (2022). Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering. mAbs. 14(1). 2068213–2068213. 6 indexed citations
7.
Watanabe, Hiroo, Yoshinao Ruike, Zenjiro Sampei, et al.. (2021). A Novel Total Drug Assay for Quantification of Anti-C5 Therapeutic Monoclonal Antibody in the Presence of Abundant Target. The AAPS Journal. 23(1). 21–21. 2 indexed citations
8.
Ito, Shunsuke, Masayuki Mishima, Mariko Yano, et al.. (2019). In vitrohuman helper T-cell assay to screen antibody drug candidates for immunogenicity. Journal of Immunotoxicology. 16(1). 125–132. 20 indexed citations
9.
Sampei, Zenjiro, Kenta Haraya, Tatsuhiko Tachibana, et al.. (2018). Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody. PLoS ONE. 13(12). e0209509–e0209509. 40 indexed citations
10.
Sampei, Zenjiro, Tomoyuki Igawa, Tetsuhiro Soeda, et al.. (2014). Non–antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity. mAbs. 7(1). 120–128. 16 indexed citations
11.
Muto, Atsushi, Kazutaka Yoshihashi, Minako Takeda, et al.. (2014). Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A. Blood. 124(20). 3165–3171. 74 indexed citations
12.
Sampei, Zenjiro, Tomoyuki Igawa, Tetsuhiro Soeda, et al.. (2013). Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity. PLoS ONE. 8(2). e57479–e57479. 246 indexed citations
13.
Igawa, Tomoyuki, Hiroyuki Tsunoda, Taichi Kuramochi, et al.. (2011). Engineering the variable region of therapeutic IgG antibodies. mAbs. 3(3). 243–252. 117 indexed citations
14.
Sampei, Zenjiro. (2004). Gene cloning and deletion analysis of chitinase J from alkaliphilic Bacillus sp. strain J813. Nucleic Acids Symposium Series. 48(1). 167–168. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026